Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia

G Rajagopal; J. G. Graham; F. F. A. Haut

doi:10.1111/j.1365-2788.2006.00865.x

Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia

G Rajagopal, J. G. Graham, F. F. A. Haut

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Abstract

While clozapine is an effective treatment for refractory schizophrenia, its use is limited by haematological side effects. Treatment options that allow continued prescription of clozapine by tackling these side effects will greatly aid patients for whom this medication is all too often their only hope of recovery.

Original language	English
Pages (from-to)	82-85
Number of pages	4
Journal	Journal of Intellectual Disability Research
Volume	51
Issue number	1
DOIs	https://doi.org/10.1111/j.1365-2788.2006.00865.x
Publication status	Published - 2007

Keywords

Adult
Agranulocytosis
Clozapine
Comorbidity
Drug Therapy, Combination
Granulocyte Colony-Stimulating Factor
Humans
Injections, Subcutaneous
Intellectual Disability
Leukocyte Count
Leukopoiesis
Lithium Carbonate
Male
Schizophrenia, Paranoid

Access to Document

10.1111/j.1365-2788.2006.00865.x

Cite this

@article{7f207c8ed0a04a2dbce86f470fa435c4,

title = "Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia",

abstract = "While clozapine is an effective treatment for refractory schizophrenia, its use is limited by haematological side effects. Treatment options that allow continued prescription of clozapine by tackling these side effects will greatly aid patients for whom this medication is all too often their only hope of recovery.",

keywords = "Adult, Agranulocytosis, Clozapine, Comorbidity, Drug Therapy, Combination, Granulocyte Colony-Stimulating Factor, Humans, Injections, Subcutaneous, Intellectual Disability, Leukocyte Count, Leukopoiesis, Lithium Carbonate, Male, Schizophrenia, Paranoid",

author = "G Rajagopal and Graham, {J. G.} and Haut, {F. F. A.}",

year = "2007",

doi = "10.1111/j.1365-2788.2006.00865.x",

language = "English",

volume = "51",

pages = "82--85",

journal = "Journal of Intellectual Disability Research",

issn = "0964-2633",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia

AU - Rajagopal, G

AU - Graham, J. G.

AU - Haut, F. F. A.

PY - 2007

Y1 - 2007

N2 - While clozapine is an effective treatment for refractory schizophrenia, its use is limited by haematological side effects. Treatment options that allow continued prescription of clozapine by tackling these side effects will greatly aid patients for whom this medication is all too often their only hope of recovery.

AB - While clozapine is an effective treatment for refractory schizophrenia, its use is limited by haematological side effects. Treatment options that allow continued prescription of clozapine by tackling these side effects will greatly aid patients for whom this medication is all too often their only hope of recovery.

KW - Adult

KW - Agranulocytosis

KW - Clozapine

KW - Comorbidity

KW - Drug Therapy, Combination

KW - Granulocyte Colony-Stimulating Factor

KW - Humans

KW - Injections, Subcutaneous

KW - Intellectual Disability

KW - Leukocyte Count

KW - Leukopoiesis

KW - Lithium Carbonate

KW - Male

KW - Schizophrenia, Paranoid

U2 - 10.1111/j.1365-2788.2006.00865.x

DO - 10.1111/j.1365-2788.2006.00865.x

M3 - Article

C2 - 17181606

SN - 0964-2633

VL - 51

SP - 82

EP - 85

JO - Journal of Intellectual Disability Research

JF - Journal of Intellectual Disability Research

IS - 1

ER -

Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia

Abstract

Keywords

Access to Document

Fingerprint

Cite this